6th Age-Related Disease Therapeutics Summit

Kongressthemen
In 2024, age-related disease biotechs are set to shine, building on 2023's milestones such as Eli Lilly's partnership with BioAge to test muscle rejuvenation therapy and Chan Zuckerberg Biolabs tapping into immune cell engineering to eradicate age-related diseases.

To successfully navigate the volatile market of 2024, rapid proof-of-concept studies and validated clinical endpoints are crucial for funding and pipeline progress.

Wissenschaftliche Fach-Gesellschaft
Hanson Wade

Anmerkungen
Brochure: https://go.evvnt.com/2248550-3?pid=4832

Speakers: Abdulkader Rahmo, President and CSO, SMS Biotech, AndAndrew Butler, Professor, Department of Pharmacology and Physiology, Institute for Translational Neuroscience and more

https://go.evvnt.com/2248550-2?pid=4832

Frau Mara Milhailovic